Bit.bio is an award-winning synthetic biology enterprise, coding human cells for health. The company's aim is to develop a platform capable of producing consistent batches of every human cell. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies.

Bit.bio Executive Leadership

• Kathryn Corzo, President and Chief Operating Officer
• Bernhard Klemen, Chief Financial Officer
• Mark Kotter, Founder and CEO, Board Member
• Paul Morrill, Chief Business Officer

Bit.bio Board Members

• Hermann Hauser, Chair of the Board
• Weslie Janeway, Board Member
• Alan S. Roemer, Board Member
• Gregory Winter, Board Member

Bit.bio Scientific Advisory Board

• Roger Pedersen, Chief Scientific Advisor
• Anil Dhawan, Scientific Advisory Board Member
• Thore Graepel, Scientific Advisory Board Member
• Katy Rezvani, Scientific Advisory Board Member
• Loïc Vincent, Scientific Advisory Board Member
• Marius Wernig, Scientific Advisory Board Member